AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (January 23, 2007). doi:10.1152/ajpendo.00524.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/E1426    most recent
00524.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burt, M. G
Right arrow Articles by Ho, K. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burt, M. G
Right arrow Articles by Ho, K. K.
Submitted on September 26, 2006
Accepted on January 19, 2007

Protein Metabolism in Glucocorticoid Excess: Study in Cushing’s Syndrome and the Effect of Treatment

Morton G Burt1, James Gibney2, and Ken KY Ho1*

1 Pituitary Research Unit, Garvan Institute of Medical Research, Sydney, New South Wales, Australia; Department of Endocrinology, St Vincents Hospital, Sydney, New South Wales, Australia; University of New South Wales, Sydney, New South Wales, Australia
2 Pituitary Research Unit, Garvan Institute of Medical Research, Sydney, New South Wales, Australia

* To whom correspondence should be addressed. E-mail: k.ho{at}garvan.unsw.edu.au.

How protein metabolism is perturbed during chronic glucocorticoid excess is poorly understood. The aims were to investigate the impact of chronic glucocorticoid excess and restoration of eucortisolemia in Cushing’s syndrome (CS) on whole body protein metabolism. 18 subjects with CS and 18 normal subjects (NS) underwent assessment of body composition using DXA and whole body protein turnover with a 3h constant infusion of l-[13C] leucine, allowing calculation of rates of leucine appearance (LRa), leucine oxidation (Lox) and leucine incorporation into protein (LIP). 10 subjects with CS were restudied after restoration of eucortisolemia. Percentage FM was greater (43.9±1.6% vs 33.8±2.4%, p=0.002) and LBM lower (52.7±1.6% vs 62.1±2.3%, p=0.002) in CS. LBM was significantly correlated (r2>0.44, p<0.005) to LRa, Lox and LIP in both groups. After correcting for LBM, LRa (133±5 vs 116±5µmol/min, p=0.02) and Lox (29±1 vs 24±1µmol/min, p=0.01) were greater in CS. FM significantly correlated (r2=0.23, p<0.05) with LRa and LIP, but not Lox in CS. In multiple regression, LBM was an independent determinant of all 3 indices of leucine turnover, FM of LRa and LIP and CS of Lox. Following restoration of eucortisolemia, Lox was reduced ({bigtriangleup}-7.5±2.6 µmol/min, p=0.02) and LIP increased ({bigtriangleup}+15.2±6.2 µmol/min, p=0.04). In summary, whole body protein metabolism in CS is influenced by changes in body composition and glucocorticoid excess per se, which increases protein oxidation. Enhanced protein oxidation is a likely explanation for the reduced protein mass in CS. Successful treatment of CS reduces protein oxidation and increases protein synthesis to prevent ongoing protein loss.




This article has been cited by other articles:


Home page
J EndocrinolHome page
D. P Macfarlane, S. Forbes, and B. R Walker
Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome
J. Endocrinol., May 1, 2008; 197(2): 189 - 204.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.